Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Kanazawa Municipal Hospital, Kanazawa, Japan.
J Cardiol. 2020 Dec;76(6):573-579. doi: 10.1016/j.jjcc.2020.06.010. Epub 2020 Jun 30.
Obstructive sleep apnea (OSA) is characterized by augmented sympathetic nerve activity. In our previous study, patients with OSA and an apnea-hyperpnea index (AHI)>55events/h showed increased single-unit muscle sympathetic nerve activity compared to patients with OSA and AHI of 30-55events/h. However, the prognostic impact in these patients remains unclear.
Ninety-one OSA patients were included. All patients who had indication for continuous positive airway pressure (CPAP) were treated with CPAP. Patients were divided into three groups: mild/moderate OSA (S), AHI<30events/h (n=44); severe OSA (SS), AHI 30-55events/h (n=29); and very severe OSA (VSS), AHI>55events/h (n=18). The primary endpoint was a composite outcome composed of death, cardiovascular events, stroke, and heart failure with hospitalization.
In the 5-year follow-up, the primary event rate in the SS group [3 events (7%)] was the same as that in the S group [3 events (10%)]. However, the VSS group showed a significantly higher primary event rate among the three groups [6 events (33%), p<0.05]. In Cox regression analysis, the VSS group had the highest hazard ratio compared to other risk factors.
CPAP was effective for preventing cardiovascular disease in patients with severe OSA, however patients with very severe OSA still had a high event rate, indicating that CPAP treatment might be insufficient to reduce the OSA-related risk burden in patients with very severe OSA. Additional systemic medical treatment for CPAP might be needed in patients with very severe OSA.
阻塞性睡眠呼吸暂停(OSA)的特征是交感神经活动增强。在我们之前的研究中,与 AHI 为 30-55 次/小时的 OSA 患者相比,AHI>55 次/小时的 OSA 患者的单单位肌肉交感神经活动增加。然而,这些患者的预后影响尚不清楚。
纳入 91 例 OSA 患者。所有有持续气道正压通气(CPAP)指征的患者均接受 CPAP 治疗。患者分为三组:轻度/中度 OSA(S),AHI<30 次/小时(n=44);重度 OSA(SS),AHI 为 30-55 次/小时(n=29);极重度 OSA(VSS),AHI>55 次/小时(n=18)。主要终点是由死亡、心血管事件、中风和心力衰竭住院组成的复合终点。
在 5 年的随访中,SS 组[3 例(7%)]的主要事件发生率与 S 组[3 例(10%)]相同。然而,VSS 组的主要事件发生率明显高于其他三组[6 例(33%),p<0.05]。在 Cox 回归分析中,与其他危险因素相比,VSS 组的危险比最高。
CPAP 对预防重度 OSA 患者的心血管疾病有效,但重度 OSA 患者的事件发生率仍然较高,这表明 CPAP 治疗可能不足以降低重度 OSA 患者的 OSA 相关风险负担。对于重度 OSA 患者,可能需要 CPAP 以外的全身药物治疗。